PHOENIX MOLECULAR DESIGNS has a total of 14 patent applications. It decreased the IP activity by 81.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are WARNEFORD HEALTHCARE LTD, NEURAD LTD and MEZZION PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Colombia | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Annedi Subhash | 10 |
#2 | Jayanthan Aarthi | 10 |
#3 | Dunn Sandra E | 10 |
#4 | Daynard Timothy S | 10 |
#5 | Nagireddy Jaipal Reddy | 10 |
#6 | Van Drie John H | 10 |
#7 | Huynh My-My | 9 |
#8 | Sandra E Dunn | 2 |
#9 | Subhash Annedi | 2 |
#10 | Timothy S Daynard | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020165646A1 | Crystalline forms of an rsk inhibitor | |
AU2017220738A1 | Carboxamide derivatives useful as RSK inhibitors |